Fiera Capital Corp Takes $519,000 Position in The Allstate Co. (NYSE:ALL)

Fiera Capital Corp acquired a new position in shares of The Allstate Co. (NYSE:ALL) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,735 shares of the insurance provider’s stock, valued at approximately $519,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC acquired a new stake in shares of Allstate during the 3rd quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new stake in Allstate during the 3rd quarter worth approximately $29,000. Versant Capital Management Inc boosted its position in shares of Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after buying an additional 78 shares during the period. Family Firm Inc. acquired a new stake in Allstate in the 2nd quarter valued at $38,000. Finally, MCF Advisors LLC boosted its holdings in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after buying an additional 84 shares during the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, CEO Thomas J. Wilson sold 90,000 shares of the business’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at $15,880,915.68. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the completion of the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the sale, the chief executive officer now directly owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock valued at $34,967,665 in the last ninety days. 1.80% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on ALL shares. Wells Fargo & Company boosted their price target on Allstate from $175.00 to $186.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. BMO Capital Markets increased their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a report on Friday, October 18th. UBS Group lifted their price objective on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. JPMorgan Chase & Co. raised their price objective on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research note on Thursday, October 10th. Finally, Keefe, Bruyette & Woods raised their target price on Allstate from $222.00 to $225.00 and gave the company an “outperform” rating in a research report on Wednesday, November 6th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Allstate presently has an average rating of “Moderate Buy” and a consensus price target of $212.56.

Allstate Price Performance

Shares of NYSE:ALL opened at $196.90 on Monday. The firm has a market cap of $52.14 billion, a price-to-earnings ratio of 12.75, a P/E/G ratio of 1.76 and a beta of 0.48. The Allstate Co. has a fifty-two week low of $128.33 and a fifty-two week high of $198.79. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The firm has a fifty day moving average price of $189.09 and a 200 day moving average price of $175.85.

Allstate (NYSE:ALL) last posted its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $2.20 by $1.71. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The firm had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the prior year, the company earned $0.81 EPS. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. As a group, sell-side analysts expect that The Allstate Co. will post 15.34 earnings per share for the current fiscal year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.